CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade IDEXX Laboratories, Inc. - IDXX CFD

521.39
0.53%
Market Trading Hours* (UTC) Open now
Closes on Thursday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.51
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

IDEXX Laboratories Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 518.62
Open* 518.97
1-Year Change* 23.05%
Day's Range* 518.97 - 527.91
52 wk Range 372.50-564.74
Average Volume (10 days) 466.89K
Average Volume (3 months) 10.48M
Market Cap 39.67B
P/E Ratio 48.74
Shares Outstanding 83.05M
Revenue 3.59B
EPS 9.80
Dividend (Yield %) N/A
Beta 1.25
Next Earnings Date Feb 5, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 6, 2023 521.39 0.07 0.01% 521.32 529.29 515.97
Dec 5, 2023 518.62 9.81 1.93% 508.81 519.32 504.87
Dec 4, 2023 516.36 20.66 4.17% 495.70 517.06 495.70
Dec 1, 2023 482.24 19.34 4.18% 462.90 483.55 462.22
Nov 30, 2023 465.69 1.27 0.27% 464.42 466.24 458.11
Nov 29, 2023 466.29 -4.05 -0.86% 470.34 476.25 464.54
Nov 28, 2023 470.24 -4.18 -0.88% 474.42 475.46 464.24
Nov 27, 2023 479.17 4.62 0.97% 474.55 480.35 471.57
Nov 24, 2023 477.56 3.24 0.68% 474.32 479.62 472.97
Nov 22, 2023 477.88 -0.41 -0.09% 478.29 483.18 475.02
Nov 21, 2023 477.57 6.30 1.34% 471.27 479.75 466.57
Nov 20, 2023 472.77 13.30 2.89% 459.47 473.58 457.37
Nov 17, 2023 463.45 -3.15 -0.68% 466.60 466.87 456.13
Nov 16, 2023 466.53 4.81 1.04% 461.72 468.78 460.66
Nov 15, 2023 460.45 8.19 1.81% 452.26 465.91 449.10
Nov 14, 2023 454.13 12.77 2.89% 441.36 458.61 441.36
Nov 13, 2023 432.14 6.49 1.52% 425.65 435.92 424.47
Nov 10, 2023 428.61 8.01 1.90% 420.60 431.72 414.86
Nov 9, 2023 418.53 -9.43 -2.20% 427.96 431.83 417.25
Nov 8, 2023 427.58 1.54 0.36% 426.04 429.67 419.94

IDEXX Laboratories, Inc. Events

Time (UTC) Country Event
Monday, February 5, 2024

Time (UTC)

13:30

Country

US

Event

Q4 2023 IDEXX Laboratories Inc Earnings Release
Q4 2023 IDEXX Laboratories Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 3367.32 3215.36 2706.66 2406.91 2213.24
Revenue 3367.32 3215.36 2706.66 2406.91 2213.24
Cost of Revenue, Total 1362.99 1325.93 1135.61 1041.36 971.7
Gross Profit 2004.34 1889.43 1571.04 1365.55 1241.54
Total Operating Expense 2468.56 2283.33 2012.13 1854.06 1721.91
Selling/General/Admin. Expenses, Total 847.353 794.295 734.667 678.41 626.644
Research & Development 254.82 161.009 141.249 133.193 117.863
Interest Expense (Income) - Net Operating 3.4 2.1 0.6 1.1 3.1
Operating Income 898.765 932.028 694.524 552.846 491.335
Interest Income (Expense), Net Non-Operating -38.793 -29.374 -32.539 -30.628 -33.593
Net Income Before Taxes 859.972 902.654 661.985 522.218 457.742
Net Income After Taxes 679.089 744.844 582.131 427.792 379.147
Minority Interest 0 0.001 -0.355 -0.072 -0.016
Net Income Before Extra. Items 679.089 744.845 581.776 427.72 379.131
Net Income 679.089 744.845 581.776 427.72 377.031
Income Available to Common Excl. Extra. Items 679.089 744.845 581.776 427.72 379.131
Income Available to Common Incl. Extra. Items 679.089 744.845 581.776 427.72 377.031
Diluted Net Income 679.089 744.845 581.776 427.72 377.031
Diluted Weighted Average Shares 84.6 86.572 86.722 87.542 88.47
Diluted EPS Excluding Extraordinary Items 8.02706 8.60376 6.70852 4.88588 4.28542
Diluted Normalized EPS 8.02706 8.65283 6.73388 4.88588 4.30976
Unusual Expense (Income) 2.6
Total Extraordinary Items -2.1
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 943.63 900.195 828.568 841.661 860.546
Revenue 943.63 900.195 828.568 841.661 860.546
Cost of Revenue, Total 370.78 357.224 343.641 335.035 346.514
Gross Profit 572.85 542.971 484.927 506.626 514.032
Total Operating Expense 647.486 619.796 602.041 596.833 681.48
Selling/General/Admin. Expenses, Total 230.201 217.905 214.982 213.785 211.745
Research & Development 46.505 44.667 43.418 48.013 123.221
Operating Income 296.144 280.399 226.527 244.828 179.066
Interest Income (Expense), Net Non-Operating -10.215 -12.711 -13.312 -10.645 -7.983
Net Income Before Taxes 285.929 267.688 213.215 234.183 171.083
Net Income After Taxes 224.236 214.054 172.207 180.938 131.979
Minority Interest 0 0 0
Net Income Before Extra. Items 224.236 214.054 172.207 180.938 131.979
Net Income 224.236 214.054 172.207 180.938 131.979
Income Available to Common Excl. Extra. Items 224.236 214.054 172.207 180.938 131.979
Income Available to Common Incl. Extra. Items 224.236 214.054 172.207 180.938 131.979
Diluted Net Income 224.236 214.054 172.207 180.938 131.979
Diluted Weighted Average Shares 83.983 83.959 83.826 84.113 84.858
Diluted EPS Excluding Extraordinary Items 2.67002 2.54951 2.05434 2.15113 1.55529
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 2.67002 2.54951 2.05434 2.15113 1.55529
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1101.48 955.655 1062.74 679.639 654.172
Cash and Short Term Investments 112.546 144.454 383.928 90.326 123.794
Cash & Equivalents 112.546 144.454 383.928 90.326 123.794
Short Term Investments 0
Total Receivables, Net 490.903 425.584 374.742 307.487 272.623
Accounts Receivable - Trade, Net 442.473 406.12 355.266 286.971 258.525
Total Inventory 367.823 269.03 209.873 195.019 173.303
Prepaid Expenses 41.742 41.997 34.556 31.992 30.314
Other Current Assets, Total 88.463 74.59 59.639 54.815 54.138
Total Assets 2746.76 2437.2 2294.56 1832.47 1537.35
Property/Plant/Equipment, Total - Net 768.092 692.768 646.338 614.452 437.27
Property/Plant/Equipment, Total - Gross 1474.01 1341.16 1233.25 1133.48 906.003
Accumulated Depreciation, Total -705.914 -648.391 -586.914 -519.03 -468.733
Goodwill, Net 361.795 359.345 243.347 239.724 214.489
Intangibles, Net 97.672 99.035 52.543 58.468 41.825
Long Term Investments 55.5 18.598 12.065 13.657 10.894
Other Long Term Assets, Total 212.541 187.836 179.52 145.349 147.43
Total Current Liabilities 1235.8 763.579 582.761 725.337 770.444
Accounts Payable 110.221 116.14 74.558 72.172 69.534
Accrued Expenses 385.115 416.304 372.972 288.944 233.471
Notes Payable/Short Term Debt 579 73.5 0 288.765 398.937
Other Current Liabilities, Total 86.485 82.639 85.243 75.456 68.502
Total Liabilities 2138.03 1747.21 1662.47 1655 1546.86
Total Long Term Debt 694.387 775.205 858.492 599.488 499.571
Long Term Debt 694.387 775.205 858.492 599.488 499.571
Deferred Income Tax 8.15 8.935 11.707 33.024 29.267
Minority Interest 0 0.707 0.352 0.28
Other Liabilities, Total 199.688 199.492 208.806 296.801 247.3
Total Equity 608.737 689.992 632.088 177.473 -9.513
Common Stock 15.901 16.407 15.149 15.033 15.033
Additional Paid-In Capital 1463.21 1377.32 1294.85 1213.52 1138.22
Retained Earnings (Accumulated Deficit) 3599.53 2920.44 2175.59 1595.65 1167.93
Treasury Stock - Common -4392.11 -3570.69 -2799.89 -2600.54 -2288.9
Unrealized Gain (Loss) -0.172 -0.126 -0.272 0.11 -0.157
Other Equity, Total -77.624 -53.358 -53.343 -46.292 -41.634
Total Liabilities & Shareholders’ Equity 2746.76 2437.2 2294.56 1832.47 1537.35
Total Common Shares Outstanding 82.894 84.562 85.449 85.471 86.099
Note Receivable - Long Term 149.688 123.966 98.01 81.186 31.269
Current Port. of LT Debt/Capital Leases 74.982 74.996 49.988
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1384.23 1179.03 1149.45 1101.48 1058.86
Cash and Short Term Investments 331.696 132.838 111.367 112.546 99.176
Cash & Equivalents 331.696 132.838 111.367 112.546 99.176
Total Receivables, Net 521.865 532.287 519.861 490.903 452.897
Accounts Receivable - Trade, Net 503.653 511.982 492.669 442.473 430.327
Total Inventory 393.974 395.141 391.011 367.823 354.975
Prepaid Expenses 49.875 38.918 40.084 41.742 39.696
Other Current Assets, Total 86.82 79.841 87.123 88.463 112.115
Total Assets 3086.4 2870.81 2808.4 2746.76 2640.07
Property/Plant/Equipment, Total - Net 804.883 797.418 780.499 768.092 722.508
Goodwill, Net 361.766 364.206 362.942 361.795 355.292
Intangibles, Net 87.129 90.932 94.361 97.672 99.968
Long Term Investments 54.333 55.391 54.271 55.5 51.76
Note Receivable - Long Term 159.196 159.369 153.757 149.688 142.031
Other Long Term Assets, Total 234.867 224.465 213.122 212.541 209.649
Total Current Liabilities 970.193 883.859 1065.63 1235.8 1189.94
Accounts Payable 112.609 107.664 117.709 110.221 110.144
Accrued Expenses 370.053 343.016 330.763 385.115 371.286
Notes Payable/Short Term Debt 250 264 431.5 579 633
Current Port. of LT Debt/Capital Leases 149.99 74.991 74.986 74.982 0
Other Current Liabilities, Total 87.541 94.188 110.671 86.485 75.515
Total Liabilities 1789 1776.94 1967.3 2138.03 2164.07
Total Long Term Debt 618.813 696.844 696.362 694.387 760.814
Long Term Debt 618.813 696.844 696.362 694.387 760.814
Deferred Income Tax 10.594 5.568 5.826 8.15 14.486
Minority Interest
Other Liabilities, Total 189.397 190.674 199.48 199.688 198.823
Total Equity 1297.41 1093.86 841.101 608.737 475.999
Common Stock 16.268 16.253 15.896 15.901 15.885
Additional Paid-In Capital 1543.02 1515.2 1489.9 1463.21 1437.53
Retained Earnings (Accumulated Deficit) 4250.05 4037.82 3813.58 3599.53 3427.32
Treasury Stock - Common -4437.04 -4401.74 -4401.67 -4392.11 -4323.84
Unrealized Gain (Loss) -0.166 -0.165 -0.166 -0.172 -0.178
Other Equity, Total -74.725 -73.5 -76.449 -77.624 -80.716
Total Liabilities & Shareholders’ Equity 3086.4 2870.81 2808.4 2746.76 2640.07
Total Common Shares Outstanding 83.068 83.06 83.004 82.894 82.995
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 679.089 744.844 582.131 427.792 377.047
Cash From Operating Activities 542.984 755.546 648.063 459.158 400.084
Cash From Operating Activities 111.9 104.596 95.998 88.011 83.178
Deferred Taxes -35.065 -3.377 -38.082 6.162 1.209
Non-Cash Items 60.59 47.006 39.777 42.162 30.29
Cash Taxes Paid 239.8 161.7 110.7 88 69.7
Cash Interest Paid 39.5 30.5 32.4 29.7 34.7
Changes in Working Capital -273.53 -137.523 -31.761 -104.969 -91.64
Cash From Investing Activities -195.35 -292.967 -109.376 -205.528 138.602
Capital Expenditures -158.838 -119.549 -107.876 -155.224 -122.936
Other Investing Cash Flow Items, Total -36.512 -173.418 -1.5 -50.304 261.538
Cash From Financing Activities -370.936 -697.414 -248.416 -286.409 -597.799
Financing Cash Flow Items -17.472 -20.702 -27.304 -10.582 -10.641
Issuance (Retirement) of Stock, Net -783.964 -700.212 -131.487 -265.552 -331.118
Issuance (Retirement) of Debt, Net 430.5 23.5 -89.625 -10.275 -256.04
Foreign Exchange Effects -8.606 -4.639 3.331 -0.689 -4.768
Net Change in Cash -31.908 -239.474 293.602 -33.468 -63.881
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 214.054 679.089 506.882 325.944 193.965
Cash From Operating Activities 183.912 542.984 369.556 180.556 114.706
Cash From Operating Activities 28.331 111.9 83.18 54.633 26.511
Deferred Taxes -3.757 -35.065 -36.89 -23.517 -5.028
Non-Cash Items 15.893 60.59 45.981 30.447 13.5
Cash Taxes Paid 7.2 239.8 179.72 128.325 11.4
Changes in Working Capital -70.609 -273.53 -229.597 -206.951 -114.242
Cash From Investing Activities -39.511 -195.35 -146.121 -96.924 -41.838
Capital Expenditures -39.511 -158.838 -109.609 -71.924 -41.838
Other Investing Cash Flow Items, Total -36.512 -36.512 -25 0
Cash From Financing Activities -146.081 -370.936 -254.216 -105.387 -13.48
Financing Cash Flow Items -11.377 -17.472 -16.282 -13.206 -10.338
Issuance (Retirement) of Stock, Net 12.796 -783.964 -722.434 -554.681 -254.642
Issuance (Retirement) of Debt, Net -147.5 430.5 484.5 462.5 251.5
Foreign Exchange Effects 0.501 -8.606 -14.497 -8.337 0.776
Net Change in Cash -1.179 -31.908 -45.278 -30.092 60.164
Cash Interest Paid 39.5
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.8895 8209522 45187 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2072 5152755 137148 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.5434 3771574 97303 2023-06-30 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 4.3281 3592832 214529 2023-06-30 LOW
Fundsmith LLP Investment Advisor 3.5676 2961551 7355 2023-06-30 LOW
Baron Capital Management, Inc. Investment Advisor/Hedge Fund 2.863 2376632 20389 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.4249 2012999 66660 2023-06-30 LOW
Invesco Capital Management (QQQ Trust) Investment Advisor 1.7036 1414239 7593 2023-09-30 LOW
William Blair & Company, L.L.C. (Research) Research Firm 1.4361 1192133 -17061 2023-06-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.4199 1178695 -78372 2023-06-30 LOW
Brown Advisory Investment Advisor/Hedge Fund 1.3987 1161124 24741 2023-09-30 LOW
Franklin Advisers, Inc. Investment Advisor/Hedge Fund 1.3734 1140082 13910 2023-06-30 LOW
Fundsmith Investment Services Ltd. Investment Advisor 1.2282 1019528 15108 2023-06-30 LOW
Capital World Investors Investment Advisor 1.2132 1007073 8310 2023-06-30 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.0103 838655 -196239 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9934 824629 49030 2022-12-31 LOW
Principal Global Investors (Equity) Investment Advisor 0.9692 804548 -82966 2023-06-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.9465 785686 -11169 2023-06-30 LOW
Ayers (Jonathan W) Individual Investor 0.8937 741868 147571 2023-09-06 MED
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8372 694960 21103 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

IDEXX Labs Company profile

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, IDEXX Laboratories, Inc. revenues increased 19% to $3.22B. Net income increased 28% to $744.8M. Revenues reflect CAG segment increase of 21% to $5.42B, Water segment increase of 14% to $146.5M, United States segment increase of 18% to $2B, Canada segment increase of 30% to $139.7M, Germany segment increase of 23% to $146.8M. Net income benefited from CAG segment income increase of 43% to $824M.

Equity composition

Common Stock $.10 Par, 06/11, 120M auth., 98,835,000 issd., less 42,004,000 shs. in Treas. @ $1.16B. Insiders control approx.1.09%. IPO: 4/92, 1.5M shares @ $20.50 by Lehman Brothers. PO: 10/95, 4.6M shares @ $35 by Cowen & Company. 11/07, 6/95 & 10/93, 2-for-1 stock splits. 06/15, 2-for-1, Stock Split.

Industry: Veterinary Medical Equipment & Supplies

One Idexx Drive
WESTBROOK
MAINE 04092-2041
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

XRP/USD

0.64 Price
-0.960% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

70.54 Price
+1.680% 1D Chg, %
Long position overnight fee -0.0205%
Short position overnight fee -0.0014%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

15,880.30 Price
+0.570% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

43,272.50 Price
-1.360% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading